ORIGINAL RESEARCH article
Front. Oncol.
Sec. Gynecological Oncology
This article is part of the Research TopicAdvances in Diagnosis and Treatment of Endometrial CancerView all 26 articles
Clinicopathological and Molecular Features of Gynecologic Perivascular Epithelioid Cell Tumors: A Single-Center Study
Provisionally accepted
- 1Shandong University Qilu Hospital Department of Pathology, Jinan, China
- 2Rushan People's Hospital, Rushan, China
- 3Qilu Hospital of Shandong University Qingdao, Qingdao, China
- 4Hospital for Reproductive Medicine Affiliated to Shandong University, Jinan, China
- 5Pathology, Shandong University, School of Basic Medical Science, Jinan, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
ABSTRACT Background: Perivascular epithelioid cell tumors (PEComas) are rare neoplasms characeterized by the expression of both melanocytic and myoid markers. Gynecologic PEComa may show overlapping with smooth muscle tumors and other uterine tumors. The rarity and ill-defined risk stratification make the diagnosis challenging. The current study was aimed to more fully characterize gynecologic PEComas. Methods: We investigated the clinicopathological and immunohistochemical features of nine gynecological PEComas from a single center. The molecular landscape was assessed using a combined DNA-RNA hybrid capture-based comprehensive genomic profiling assay. Results: Patients, aged from 27 to 79 years old, presented with the disease predominantly located in the uteri (5/9) and cervix (3/9). Histologically, six cases were classified as malignant and three as having uncertain malignant potential. All tumors were composed of epithelioid or spindled cells arranged around the vessels, with variable nuclear atypia and necrosis. Immunohistochemical analysis revealed universal HMB45 and TFE3 positivity, and variable myoid marker expression. HMB45 was confirmed as the most sensitive diagnostic marker. Mutually exclusive genetic alterations were identified in all six tested cases with TSC2 mutations/deletions in three tumors and TFE3 fusions in another three. And here we reported a novel YAP1-TFE3 gene fusion in gynecological site. It was found TSC2-altered tumors harbored more additional mutations, whereas TFE3-rearranged tumors occurred in younger patients. Most cases showed malignant potential or malignancy, necessitating risk stratification according to the current WHO algorithms. Conclusions: This study highlights the key histological and molecular features, and advocates for integrated DNA/RNA sequencing to guide prognosis and targeted therapies.
Keywords: Gynecologic, Immunohistochemistry, PEComa, TFE3, TSC2
Received: 17 Dec 2025; Accepted: 21 Jan 2026.
Copyright: © 2026 Li, Sun, Hou, Xin, Li and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Li Li
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.